Author: Kelly Cawcutt
UNMC ID at #CROI 2021
Conferences may continue to look different due to the COVID-19 pandemic, but our ID faculty remain dedicated as ever to continuing to contribute to scientific knowledge and advancement of patient care. The Conference on Retroviruses and Opportunistic Infections (CROI) was held this year from March 6-10, and UNMC had several presentations. See below for the […]
Mar 13, 2021
Clinical Consequences of Contaminated Blood Cultures in Adult Hospitalized Patients at an Institution Utilizing a Rapid Blood-Culture Identification System
Blood culture contamination results in prolonged hospital length of stay, inappropriate use of antibiotics, and increased cost as well as the associated adverse events such as falls, drug errors, and healthcare associated infections (adverse events that may occur during more prolonged hospital stay) and emergence of antibiotic resistance, C. difficile infection, and antibiotic side effects […]
Jan 27, 2021
We are HIRING! Unique Community ID Opportunity Tailored to Your Professional Interests
Here @UNMC_ID we are always excited for the opportunity to grow our Division, and below you will find our announcement of a new position we have! The Division of Infectious Diseases at the University of Nebraska Medical Center in Omaha, NE is recruiting a Community ID physician to join our growing faculty. This opportunity can […]
Jan 26, 2021
Antibiotics At the End-of-Life: Helping or Harming?
Content written by Dr. Clayton Mowrer. Early in my medical training, my father developed a rapidly-progressive type of cancer. Over the course of several months, his health declined quite quickly, and he was spending more time in the hospital than outside of it. It became uncomfortably clear that pushing forward with invasive and toxic interventions […]
Jul 21, 2020
Physical Barriers for Prevention Amidst a Pandemic – The Roles of Distancing, Masks and Eye Protection
This study provides early evidence of the efficacy of continued PPE use to prevent transmission of COVID-19, both in the community and in the healthcare setting, including continued physical distancing, facemask use and eye protection.
Jul 14, 2020
Fighting Fear in COVID-19
As we have lived through this pandemic as Infectious Diseases physicians and leaders in Infection Control and Employee Health, we also have encountered nearly unprecedented fear within our workplace.
Jul 7, 2020
Journal Club: Should vancomycin be given as prophylaxis for Clostridioides difficile infections?
The following is a review by one of our fellows, Dr. Randy McCreery, who at a recent journal club presented a paper by Johnson, et al.: Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure, Clinical Infectious Diseases, 28 September 2019. In addition, Drs. McCreery, Cawcutt, […]
Mar 10, 2020
COVID-19 – What is UNMC ID doing?
Although it has not been officially declared a pandemic by the World Health Organization (WHO), as of this morning, there were 81, 191 confirmed cases of COVID-19 and 2,768 deaths worldwide. To date, 57 of these cases are within US borders, and there are increasing cases throughout the world. UNMC & Nebraska Medicine have had […]
Feb 26, 2020
Freedom is in the Air: My Visit to Sudan, a Born-again Country
Here at UNMC ID, we are thrilled to share the global, and personal efforts, of our faculty. Please take a moment to read this excellent piece by Dr. Nada Fadul; Associate Professor, Division of Infectious Diseases, UNMC Sudan felt different this time. It was the middle of December 2019, the first anniversary of the Sudanese […]
Feb 25, 2020
Should We Add Daptomycin to β-Lactams in the Initial Treatment of Methicillin-susceptible S. aureus Bacteremia?
Content from Dr. Razan El Ramahi, originally posted in IDSA journal club. Despite the availability of active antibiotics to treat Staphylococcus aureus bacteremia (SAB), controversy still exists regarding the optimal antibiotic strategy and whether combination antibiotics improve outcomes. In small clinical studies, a possible benefit was observed by adding daptomycin to β-lactams in the treatment of SAB. However, […]
Jan 28, 2020
Recent Comments